HighTower Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Sell |
3,598
-213
| -6% | -$7.18K | ﹤0.01% | 3401 |
|
|
2025
Q1 | $121K | Buy |
3,811
+546
| +17% | +$17.4K | ﹤0.01% | 3299 |
|
|
2024
Q4 | $127K | Sell |
3,265
-37
| -1% | -$1.44K | ﹤0.01% | 3285 |
|
|
2024
Q3 | $150K | Sell |
3,302
-28
| -0.8% | -$1.27K | ﹤0.01% | 3201 |
|
|
2024
Q2 | $139K | Sell |
3,330
-2,680
| -45% | -$112K | ﹤0.01% | 3099 |
|
|
2024
Q1 | $275K | Sell |
6,010
-1,271
| -17% | -$58.2K | ﹤0.01% | 2731 |
|
|
2023
Q4 | $337K | Buy |
7,281
+104
| +1% | +$4.81K | ﹤0.01% | 2597 |
|
|
2023
Q3 | $294K | Sell |
7,177
-1,755
| -20% | -$71.9K | ﹤0.01% | 2603 |
|
|
2023
Q2 | $434K | Sell |
8,932
-429
| -5% | -$20.8K | ﹤0.01% | 2290 |
|
|
2023
Q1 | $461K | Sell |
9,361
-6,790
| -42% | -$334K | ﹤0.01% | 2159 |
|
|
2022
Q4 | $818K | Sell |
16,151
-1,484
| -8% | -$75.2K | ﹤0.01% | 1782 |
|
|
2022
Q3 | $885K | Buy |
17,635
+3,525
| +25% | +$177K | ﹤0.01% | 1667 |
|
|
2022
Q2 | $690K | Sell |
14,110
-1,489
| -10% | -$72.8K | ﹤0.01% | 1852 |
|
|
2022
Q1 | $939K | Buy |
15,599
+535
| +4% | +$32.2K | ﹤0.01% | 1783 |
|
|
2021
Q4 | $1.2M | Buy |
15,064
+10,889
| +261% | +$865K | ﹤0.01% | 1668 |
|
|
2021
Q3 | $369K | Buy |
+4,175
| New | +$369K | ﹤0.01% | 2270 |
|